Surveillance doesn’t only mean tracking confirmed clinical cases. Long before COVID-19, public-health authorities used the wastewater stream to detect viruses being shed by infected people in a community, regardless of whether those people ever presented to a clinician. The technique is one of the older and quieter pillars of vaccine-preventable disease monitoring, and the pandemic gave it a dramatic upgrade.
The polio model
Wastewater surveillance for poliovirus has been a WHO-recommended tool for decades. Polio is shed in the faeces of infected people, including asymptomatic carriers, who outnumber paralytic cases by hundreds to one. Testing community wastewater catchments can detect circulating virus weeks before, or sometimes entirely without, any clinical cases. That early signal is what triggers a vaccine response.
Australia was certified polio-free in 2000. Wastewater testing is part of how that certification is maintained: regular sampling at sentinel sites across the country, supported by NCIRS surveillance work, looks for both wild poliovirus and any vaccine-derived strain. Positive findings are exceptional and have always been linked to imported cases, never sustained local transmission.
How wastewater surveillance actually works
- Sample collection. Sterile samples are collected from sewage treatment plant inlets, manhole sites, or upstream sub-catchments. Sampling is typically 24-hour composite collection so that hourly variation evens out.
- Concentration. Viruses are concentrated from large sample volumes using filtration or precipitation.
- Nucleic acid extraction. RNA or DNA is extracted from the concentrate.
- Detection. PCR detects target genetic material with high sensitivity, often picking up signal from a small number of shedders in a catchment of tens of thousands of people.
- Genomic characterisation. Positive samples can be sequenced to identify variant or strain, important for both polio and for tracking SARS-CoV-2 evolution.
- Reporting. Results feed public-health dashboards, sometimes within 24–48 hours of sample collection.
The COVID-19 expansion
Australia’s wastewater surveillance for SARS-CoV-2 began in mid-2020 and rapidly scaled. Catchments in Victoria, NSW, Queensland, WA, SA, ACT, NT and Tasmania were brought online. Public dashboards reported weekly viral signal trends. The data complemented clinical case counts in several specific ways:
- Early warning. Viral signal in sewage typically rises 4–7 days before clinical cases do.
- Coverage where testing is incomplete. When clinical testing rates dropped (mid-2022 onwards), wastewater signal remained representative of underlying community transmission.
- Variant tracking. Wastewater sequencing detected Omicron sub-lineages in Australian catchments often before clinical sequencing caught up.
- Equity. Wastewater is agnostic to whether people seek testing, useful in catchments where clinical testing access is uneven.
What other vaccine-preventable pathogens are monitored
- Polio, ongoing, sentinel sites.
- SARS-CoV-2, continues with reduced public reporting frequency.
- RSV, being piloted in some catchments.
- Influenza, pilot programs.
- Norovirus and rotavirus, occasional surveillance windows during outbreaks.
- Hepatitis A, episodic surveillance during contamination events.
- Mpox, monitored in some catchments during the 2022–2023 outbreak.
Limitations
- It tells you something is circulating, not who. Catchment-level data doesn’t identify individuals or even specific suburbs except by intensifying sampling.
- Signal interpretation requires baseline data. A positive PCR result without context can be misread; trend analysis is what matters.
- Shedding varies by pathogen. Some pathogens shed reliably in stool (polio, SARS-CoV-2, rotavirus); others don’t (most respiratory pathogens shed primarily in respiratory secretions).
- Cost and infrastructure. Reliable surveillance requires sustained funding, sampling logistics, and laboratory capacity.
What this means for vaccination policy
Wastewater data feeds directly into immunisation policy. Detection of a polio signal would trigger a vaccination response within hours. Rising COVID-19 signal can inform timing of booster campaigns. RSV signal can inform when passive-immunisation programs for infants are activated each year. The data doesn’t replace clinical surveillance, but it adds an earlier, less-biased layer that catches what would otherwise be invisible.
Sources & further reading
General information only. This article is educational and is not a substitute for personal medical advice. Your immuniser will confirm eligibility and contraindications on the day.
TGA advertising compliance. Vaccines are referred to by disease or category in line with the Therapeutic Goods Advertising Code. Specific brands and registered indications are discussed at the consultation.